VentriJect

📍 Hellerup, Denmark🗓 Founded 2018👥 13 employees💰 Last funded Oct 2024
At VentriJect, we want to change how we work with cardiorespiratory fitness. Cardiorespiratory fitness, also expressed as VO2max, is the strongest indicator of health, according to several studies, and even small improvements in VO2max can mean a significant health improvement. Unfortunately, evaluating cardiorespiratory fitness today can be cumbersome, time-consuming, expensive and dependent on highly-trained staff. At VentriJect we want to change that. Introducing the Seismofit - a radical new approach to evaluating cardiorespiratory fitness. With high accuracy, no training required, and extreme ease of use, we can estimate your VO2max in less than 3 minutes - a fraction of the time used with other approaches. This clinical-validated and patented technology is unique and a true game-changer, and will provide significant value to the patients and the healthcare practitioners. VentriJect was established as a spin-out from a leading research center in cardiology at Aalborg University in 2018 and is situated in Hellerup near Copenhagen, Denmark.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2018
Founded
Investor geography1 country
Denmark
3
Investor activity2019–2024 · investors recorded per year
2019220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in VentriJect?
VentriJect has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did VentriJect last raise funding?
The most recent investment in VentriJect recorded on gritt.io was in October 2024.
When was VentriJect founded?
VentriJect was founded in 2018.
What industry is VentriJect in?
VentriJect operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is VentriJect based?
VentriJect is headquartered in Hellerup, Denmark.